Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

China flag China · Delayed Price · Currency is CNY
16.31
+0.12 (0.74%)
Apr 30, 2026, 3:04 PM CST
21.54%
Market Cap 2.61B
Revenue (ttm) 265.36M
Net Income (ttm) 54.21M
Shares Out 160.00M
EPS (ttm) 0.34
PE Ratio 47.97
Forward PE n/a
Dividend 0.30 (1.85%)
Ex-Dividend Date May 28, 2025
Volume 2,287,550
Average Volume 2,963,722
Open 15.51
Previous Close 16.19
Day's Range 15.51 - 16.44
52-Week Range 13.35 - 20.36
Beta 0.43
RSI 57.48
Earnings Date Apr 30, 2026

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China. [Read more]

Sector Healthcare
Founded 1998
Employees 316
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300519
Full Company Profile

Financial Performance

In 2025, SHE:300519's revenue was 265.36 million, a decrease of -0.86% compared to the previous year's 267.66 million. Earnings were 54.21 million, an increase of 7.58%.

Financial Statements

News

There is no news available yet.